Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05317312 · ClinicalTrials.gov registry record · Phase 2
Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.
A Phase 2 study of Pain and Post Operative Pain, sponsored by Mylan Specialty.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
- 1
- Study location
NCT05317312 is a Phase 2 study of Pain and Post Operative Pain that has completed, run by Mylan Specialty. The registered enrollment target is 111 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05317312, a Phase 2 study of Pain and Post Operative Pain, has completed, sponsored by Mylan Specialty.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
- 1
- Study location
Study Summary
MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG MR-107A-02
Study Locations (1)
Utah
- Research Facility 201 - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2022-06-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05317312
The ClinicalTrials.gov registry entry for NCT05317312 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (63% lower). The listed sponsor is Mylan Specialty, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05317312 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT05317312 about?
NCT05317312 is a clinical study titled "Study of MR-107A-02 in the Treatment of Post Surgical Dental Pain.". MR-107A-02 is being studied to investigate its efficacy, safety and dose-response after dental surgery.
What is the current status of trial NCT05317312?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2022-03-31. Estimated completion is 2022-06-20.
What conditions does trial NCT05317312 study?
This clinical trial studies the following conditions: Pain, Post Operative Pain, Acute Pain.
What interventions are being tested in trial NCT05317312?
The interventions under investigation include: Placebo (DRUG), MR-107A-02 (DRUG).
Who is sponsoring clinical trial NCT05317312?
This trial is sponsored by Mylan Specialty, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05317312 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
RECRUITING · Phase 2
-
Cannabidiol and Older Adult Cannabis Users
RECRUITING · Phase 2
-
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
RECRUITING · Phase 2
-
Neural Correlates of Hypoalgesia Driven by Observation
RECRUITING · Phase 2
-
Cannabis for Palliative Care in Cancer
RECRUITING · Phase 2
-
Pain After Buffered Vs Non Buffered Articaine
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.